2015
DOI: 10.1016/j.brs.2015.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex

Abstract: BackgroundThe dorsolateral prefrontal cortex (DLPFC) is a common target for repetitive transcranial magnetic stimulation (rTMS) in major depression, but the conventional “5 cm rule” misses DLPFC in > 1/3 cases. Another heuristic, BeamF3, locates the F3 EEG site from scalp measurements. MRI-guided neuronavigation is more onerous, but can target a specific DLPFC stereotaxic coordinate directly. The concordance between these two approaches has not previously been assessed.ObjectiveTo quantify the discrepancy in s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
138
0
4

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 176 publications
(143 citation statements)
references
References 47 publications
1
138
0
4
Order By: Relevance
“…20,22,46 This finding also has important implications for clinical practice and suggests that MRI targeting and adjusting for coil-to-cortex distance is unlikely to yield higher remission rates than optimal methods of approximation and a stimulation intensity of 120% MT. 47,48 Future research to identify new methods to improve the efficacy of rTMS for TRD are needed. We propose that identifying and engaging biological targets of treatment response 49 may be a more productive method of enhancing efficacy.…”
Section: Resultsmentioning
confidence: 99%
“…20,22,46 This finding also has important implications for clinical practice and suggests that MRI targeting and adjusting for coil-to-cortex distance is unlikely to yield higher remission rates than optimal methods of approximation and a stimulation intensity of 120% MT. 47,48 Future research to identify new methods to improve the efficacy of rTMS for TRD are needed. We propose that identifying and engaging biological targets of treatment response 49 may be a more productive method of enhancing efficacy.…”
Section: Resultsmentioning
confidence: 99%
“…At BIDMC TMS was delivered using a NeuroStar TMS Therapy System (Neuronetics, Inc., Malvern, Pennsylvania) or Magstim Super Rapid stimulator (Magstim Company Ltd., UK) equipped with a 70-mm figure-of-eight coil and at Cornell TMS was delivered with the NeuroStar system. DLPFC targeting was 5.5 cm anterior to the motor cortex at BIDMC and via the beam F3 method at Cornell [11]. The number of rTMS sessions was 30–36 at BIDMC and 25 at Cornell.…”
Section: Methodsmentioning
confidence: 99%
“…One of the most common targets for tDCS in the literature to date has been the dlPFC, often operationalized as EEG sites F3 and F4 in the standard 10–20 montage. The F3 site has been shown to correspond fairly closely to the dlPFC node appearing in the SN (Mir-Moghtadaei et al, 2015), suggesting that tDCS of F3 and F4 is anatomically positioned to stimulate the SN. Research studies and clinical trials of tDCS have targeted the dlPFC due to its hypothesized central role in executive function and cognitive control (Kuo and Nitsche, 2012).…”
Section: Targeting the Sn-cstc With Therapeutic Brain Stimulationmentioning
confidence: 95%